George Leong is a senior editor at Lombardi Financial. He has been involved in analyzing the stock markets for two decades, employing both fundamental and technical analysis. His overall market timing and trading knowledge are extensive in the areas of small-cap research and option trading.
George is the editor of several of Lombardi Financial’s popular financial newsletters, including Red-Hot Small-Caps, Lombardi’s Special Situations, Judgment Day Profit Letter, Pennies to Millions, and 100% Letter. He is also the editor-in-chief of a daily web newsletter called Daily Gains Letter.
In the past, George has written technical and fundamental columns for numerous stock market news web sites, and he is the author of Quick Wealth Options Strategy and Mastering 7 Proven Options Strategies. Prior to starting with Lombardi Financial, George was employed as a financial analyst with Globe Information Services.
George is married with one child. In his down time, he loves to travel. He also actively coaches competitive hockey and baseball, and enjoys playing hockey, running, and working out.
Get to know George…
What was your first job and how did you become interested in investing?
I began as an auditor for an accounting firm. Interestingly, I was able to get exposure to many different industries through this position, which triggered my interest towards analyzing companies. I started with investing in resource stocks and mutual funds back during an up-cycle in metals. I did extremely well and was instantly hooked.
What is your most memorable moment in your investing career thus far?
My most memorable moment in my investing career has to be going through the 1999 bull run and watching the subsequent meltdown. Having seen what happened then, I instantly recognized the opportunity for investors to buy on weakness following the 2008 credit meltdown that crushed the stock market.
What is your investing mantra?
Bottom up. I look at companies rather than a sector and I always combine fundamental research with technical analysis to get the full picture before I invest.
New regulations have dramatically altered the rules by which the biotech industry plays, leaving industry stalwart Valeant Pharmaceuticals International, Inc. (NYSE:VRX) struggling to catch up. Does this spell the end for the rally in VRX stock? Let’s take a look. Has Valeant Stock Finally Bottomed? Not Likely These…
When BlackBerry Limited (NASDAQ:BBRY) CEO John Chen took over the helm of this troubled smartphone-maker nearly two years ago, there was big market excitement, imagining a magical turnaround on the horizon. Of course, to achieve his goals, Chen had to deal with the massive onslaught from Apple Inc.…
Nobel Laureate Robert Shiller Says U.S. Stock Market Entering Into Bubble Territory The Dow, a sign of America’s top companies, is foreshadowing what is happening in the country today as there are some signs of an upcoming stock market crash. Whether it's banking, insurance, industrial, retail, or technology,…